NEW YORK (GenomeWeb) – Danaher today said its fourth quarter revenues from continuing operations grew 6 percent year over, helped by 11 percent growth in its diagnostic segment and a 6 percent improvement in its life sciences segment.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.